Advertisement
NLS
May 24, 2018
We want to assure you that we process your personal data in accordance with the GDPR.
Published: May 24, 2018
Top stories
Global report – April 16, 2025
Ahead of the EU Commission’s presentation of a new strategy for life sciences, four industry organizations in Sweden, Lif – the research-based pharmaceutical companies, SwedenBIO, IKEM, and Swedish Medtech, have submitted a joint statement.
Biotech Business – April 15, 2025
The European Commission has granted BioArctic’s partner Eisai’s application for Marketing Authorization of Leqembi (lecanemab) in the European Union (EU).
Nykode announces that Michael Engsig, CEO, Agnete Fredriksen, CSO & Co-founder, and Harald Gurvin, CFO, have withdrawn their recent resignations and will continue with Nykode.
CDMO – April 15, 2025
A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions, has launched with an integrated network across Europe.
Related posts
Collaboration - April 8, 2025
Circio Holding (former Targovax) and Entos Pharmaceuticals have announced the initiation of a research collaboration.
Collaboration - April 7, 2025
These partnerships are part of ContextVision’s broader strategy to engage with global ultrasound players, securing additional expertise and analytical support, and to drive advancements in data quality and clinical applications for ultrasound-based solutions.
Biotech Business - April 4, 2025
The company has announced the launch of the research project PRE-CISE in collaboration with Danish companies PreTT and TetraKit Technologies.
Collaboration - February 26, 2025
“MVA is happy to join the Danish AMR Alliance, contribute to the the crucial fight against antimicrobial resistance and help knowledge share, raise awareness and bridge current and future Swedish and Danish initiatives aiming to to make a difference for global health. As a follow-up to our 2024 Annual Summit session “AMR – challenges and initiatives […]
Collaboration - February 12, 2025
The Gates Foundation, Novo Nordisk Foundation, and Wellcome have announced the launch of the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI), a USD 50 million investment that will focus on combatting antimicrobial resistance (AMR) caused by a specific range of bacteria that are among the leading contributors to AMR-associated deaths.
Collaboration - February 11, 2025
All participants are determined to establish Europe as a global leader in Artificial Intelligence (AI), advancing AI development and application.
CDMO - February 4, 2025
The two companies have announced a strategic alliance to collaborate on the manufacturing of current pipeline programs and potential future programs based on Eleva's technology platform.
This site uses cookies
Read more about our privacy policy
The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.
The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.
The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.